Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Natural Matrix Protein (NMP) Fibers are tissue-based bioimplants developed by Induce Biologics for bone regeneration. These products utilize a proprietary processing technology that "unlocks" growth factors naturally residing within the bone matrix, making them bioavailable to stimulate bone growth. The fibers contain a cocktail of endogenous proteins, including Bone Morphogenetic Proteins (BMP-2, BMP-7), Transforming Growth Factor beta-1 (TGFβ-1), Vascular Endothelial Growth Factor (VEGF), and Platelet-Derived Growth Factor (PDGF). Regulated as a 361 HCT/P (Human Cells, Tissues, and Cellular and Tissue-Based Product), NMP Fibers provide both an osteoconductive scaffold and an osteoinductive signal. They are used in various orthopedic, spine, and dental procedures to facilitate fusion and repair of bone defects.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on natural matrix protein fibers.